FOS and fungal infectious disease: Our results and those of Wimmers et al.49 and Lee et al.50, highlight significant differences between innate immune pathways that confer resistance to bacterial and fungal infections, i.e. AP-1-driven pathways, and those involved in resistance to viral infections, i.e., IRFs and STAT1-driven pathways37.